New trends in the management of anaphylaxis in pediatric patients

Czech version

Authors: Barbora Piteková ^1,2,3; Jakub Gécz ¹; Marcel Brenner ¹; Adam Markocsy ^4,5; Miloš Jeseňák ^4,5
Authors‘ workplace: Klinika pediatrickej urgentnej medicíny, Lekárska fakulta, Univerzita Komenského a Národný ústav detských chorôb, Bratislava, Slovensko ¹; Klinika pediatrickej urológie, Lekárska fakulta, Univerzita Komenského a Národný ústav detských chorôb, Bratislava, Slovensko ²; Klinika pre deti a dorast A. Getlíka, Lekárska fakulta, Slovenská zdravotnícka univerzita a Univerzitná nemocnica Bratislava, Slovensko ³; Klinika detí a dorastu, Jesseniova lekárska fakulta v Martine, Univerzita Komenského v Bratislave a Univerzitná nemocnica, Martin, Slovensko ⁴; Ústav klinickej imunológie a lekárskej genetiky, Jesseniova lekárska fakulta v Martine, Univerzita Komenského v Bratislave a Univerzitná nemocnica, Martin, Slovensko ⁵
Published in: Čes-slov Pediat 2025; 80 (6): 304-309.
Category: Pediatric Protocols in Praxis
doi: https://doi.org/10.55095/CSPediatrie2025/036

Overview

Piteková B, Gécz J, Brenner M, Markocsy A, Jeseňák M. New trends in the management of anaphylaxis in pediatric patients

Anaphylaxis is a pediatric emergency. Early recognition and correct management are core components to deal with this life-threatening situation. Recently published recommendations emphasize the critical importance of rapid recognition of anaphylaxis symptoms and epinephrin administration without delay. The proper management of pediatric patients with anaphylaxis receives increased attention today and recommendations for clinical practice have been updated.

Keywords:

corticosteroids – Pediatrics – anaphylaxis – epinephrin – antihistamines

Sources

1. Tanverdi MS, Wiersma A, Kim KM, et al. Anaphylaxis in children. Pediatr Emerg Care 2022; 38(9): 456–461.

2. Carter M, Akin C, Castells M, et al. Idiopathic anaphylaxis yardstick: Practical recommendations for clinical practice. Ann Allergy Asthma Immunol 2020; 124 (1): 16–27.

3. Pouessel G, Turner PJ, Worm M, et al. Food-induced fatal anaphylaxis: from epidemiological data to general prevention strategies. Clin Exp Allergy 2018; 48 : 1584–1593.

4. Novembre E, Gelsomino, Liotti L, et al. Fatal food anaphylaxis in adults and children. Ital J Pediatr 2024; 50(1): 40.

5. Atanaskovic-Markovic M, Gomes E, Cernadas JR, et al. Diagnosis and management of drug-induced anaphylaxis in children: an EAACI position paper. Pediatr Allergy Immunol 2019; 30 : 269–276.

6. Reber LL, Hernandez JD, Galli SJ. The pathophysiology of anaphylaxis. J Allergy Clin Immunol 2017; 140(2): 335–348.

7. Takazawa T, Oshima K, Shigeru S, et al. Drug-induced anaphylaxis in the emergency room. Acute Medicine and Surgery 2017; 4(3): 235–245.

8. Pouessel G, Jean-Bart C, Deschildre A, et al. Food-induced anaphylaxis in infancy compared to preschool age: a retrospective analysis. Clin Exp Allergy 2020; 50 : 74–81.

9. Cardona V, Ansogenui IJ, Ebisawa M, et al. World Allergy Organization Anaphylaxis Guidance 2020. World Allergy Organ J 2020; 13(10): 100472.

10. Turner PJ, Jerschow E, Umasunthar T, et al. Fatal anaphylaxis: mortality rate and risk factors. J Allergy Clin Immunol Pract 2017; 5 : 1169.

11. Pourmand A, Robinson C, Syed W, Mazer-Amirshahi M. Biphasic anaphylaxis: A review of the literature and implications for emergency management. Am J Emerg Med 2018; 36 : 1480.

12. Dribin TE, Sampson HA, Camargo C Jr, et al. Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi study. J Allergy Clin Immunol 2020; 146 : 1089.

13. Valent P, Bonadonna P, Hartmann K, et al. Why the 20% + 2 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome. Int Arch Allergy Immunol 2019; 180(1): 44–51.

14. Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol 2020; 145 : 1082–1123.

15. Sicherer SH, Simons FER. Section on allergy and immunology. Epinephrine for first-aid management of anaphylaxis. Pediatrics 2017; 139(3): e20164006.

16. Nurmatov UB, Rhatigan E, Simons FER, et al. H2-antihistamines for the treatment of anaphylaxis with and without shock: a systematic review. Ann Allergy Asthma Immunol 2014; 112 : 126–131.

17. Choo KJ, Simons FE, Sheikh A. Glucocorticoids for the treatment of anaphylaxis. Cochrane Database Syst Rev 2010; CD007596.

18. Lee S, Bellolio MF, Hess EP, et al. Time of onset and predictors of biphasic anaphylactic reactions: a systematic review and meta-analysis. J Allergy Clin Immunol Pract 2015; 3 : 408–16.e1–2.

19. Michelson KA, Monuteaux MC, Neuman MI. Glucocorticoids and hospital length of stay for children with anaphylaxis: a retrospective study. J Pediatr 2015; 167(3): 719–24.e1–3.

20. Busse PJ, Christiansen SC, Riedl MA, et al. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. J Allergy Clin Immunol Pract 2021; 9 : 132.

21. Dribin TE, Sampson HA, Camargo CA Jr, et al. Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi study. J Allergy Clin Immunol 2020; 146 : 1089.

22. Simons FE. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol 2006; 117 : 367.

23. Kapustová D, Kapustová L, Petrovičová O. Klonálne ochorenie mastocytov, alergia na jed blanokrídleho hmyzu a venómová imunoterapia. Transfuze Hematol 2025 : 1–9; ahead of print.

24. Kapustová D, Jeseňák M, Kapustová L, et al. Špecifiká alergie na blanokrídly hmyz v detskom veku a možnosti liečby. Pediatria 2022; 17(2): 63–68.

25. Wood RA, Togias A, Sicherer SH, et al. Omalizumab for the treatment of multiple food allergies. N Engl J Med 2024; 390(10): 889–899.

26. Borne GE, Daniel CP, Wagner MJ, et al. Palforzia for peanut allergy: a narrative review and update on a novel immunotherapy. Cureus 2023; 15(12): e50485.

27. Mahase E. US approves first nasal spray for anaphylaxis. BMJ 2024; 386: q1789.

28. Pecl J, Rybníček O. Anafylaxe –⁠ víme, co jíme? aneb „Aj pes vie, kto mu dáva jesť“ (slovenské přísloví). Ces-slov Pediat 2022; 77(Suppl. 1): S30–34.

29. Lieberman PL. Recognition and first-line treatment of anaphylaxis. Am J Med 2014; 127(1 Suppl): S6–11.